Overview

A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye

Status:
Completed
Trial end date:
2015-03-17
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of OPTIVE FUSION™ compared to VISMED® Multi for the management of dry eye.
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Carboxymethylcellulose Sodium
Glycerol
Hyaluronic Acid